Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 2, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inhibrx, Inc.
| -40.00K |
$24.21 | -$968,230.72 | -1.93% | 2.04M |
Mar 1
|
Scheduled
| ||||||
Inhibrx, Inc.
| -40.00K |
$24.93 | -$997,210.19 | -1.89% | 2.08M |
Feb 1 - Feb 2
|
Scheduled
| ||||||
Inhibrx, Inc.
| -40.00K |
$23.71 | -$948,598.33 | -1.86% | 2.12M |
Jan 3 - Jan 4
|
Scheduled
| ||||||
Inhibrx, Inc.
| -40.00K |
$27.22 | -$1,088,682.75 | -1.82% | 2.16M |
Dec 6
|
Scheduled
| ||||||
Inhibrx, Inc.
| -40.00K |
$33.51 | -$1,340,387.06 | -1.79% | 2.2M |
Nov 1
|
Scheduled
| ||||||
Inhibrx, Inc.
| -40.00K |
$27.82 | -$1,112,813.33 | -1.76% | 2.24M |
Oct 4
|
Scheduled
| ||||||
Inhibrx, Inc.
|
0
|
—
|
—
|
—
| 2.6M |
Sep 13
| |||||||
Inhibrx, Inc.
| -40.00K |
$14.91 | -$596,273.65 | -1.62% | 2.44M |
Sep 6
|
Scheduled
| ||||||
Inhibrx, Inc.
| -40.00K |
$18.00 | -$719,834.55 | -1.59% | 2.48M |
Aug 2 - Aug 3
|
Scheduled
| ||||||
Inhibrx, Inc.
| -40.00K |
$17.17 | -$686,800.00 | -1.57% | 2.52M |
Jul 7
|
Scheduled
| ||||||
Inhibrx, Inc.
| -400.00 |
$25.04 | -$10,016.00 | -0.02% | 2.56M |
Apr 5
|
Scheduled
| ||||||
Inhibrx, Inc.
| -17.00K |
$19.02 | -$323,340.00 | -0.66% | 2.56M |
Mar 24
|
Scheduled
| ||||||
Inhibrx, Inc.
| -17.00K |
$25.90 | -$440,300.00 | -0.66% | 2.57M |
Feb 16
|
Scheduled
| ||||||
Inhibrx, Inc.
|
0
|
—
|
—
|
—
| 2.75M |
Dec 4 - Jan 15
| |||||||
Inhibrx, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||